Atypical E2fs Control Lymphangiogenesis through Transcriptional Regulation of Ccbe1 and Flt4

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Weijts, Bart G M W ^a   van Impel, Andreas ^b   Schulte Merker, Stefan ^b,c   de Bruin, Alain ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN AND CALCIUM BINDING EGF DOMAIN 1 PROTEIN; GROWTH FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F7; TRANSCRIPTION FACTOR E2F8; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL FUNCTION; COLLAGEN AND CALCIUM BINDING EGF DOMAIN 1 GENE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME PHOSPHORYLATION; FEMALE; FETUS; FLT4 GENE; GENE; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE INDUCTION; GENE OVEREXPRESSION; GENE REPRESSION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHANGIOGENESIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; VENOUS SPROUTING; ZEBRA FISH;

ANIMALS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LYMPHANGIOGENESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84884178735     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073693     Document Type: Article

References (35)

1. Tammela T, Alitalo K, (2010) Lymphangiogenesis: Molecular mechanisms and future promise Cell. 140: 460-476.
2. Hogan BM, Herpers R, Witte M, Helotera H, Alitalo K, et al. (2009) Vegfc/Flt4 signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries Development. 136: 4001-4009.
3. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, et al. (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins Nat Immunol. 5: 74-80.
4. Schulte-Merker S, Sabine A, Petrova TV, (2011) Lymphatic vascular morphogenesis in development, physiology, and disease J Cell Biol. 193: 607-618.
5. Bos FL, Caunt M, Peterson-Maduro J, Planas-Paz L, Kowalski J, et al. (2011) CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo Circ Res. 109: 486-491.
6. Li J, Ran C, Li E, Gordon F, Comstock G, et al. (2008) Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell 14: 62-75.
7. de Bruin A, Maiti B, Jakoi L, Timmers C, Buerki R, et al. (2003) Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation J Biol Chem. 278: 42041-42049.
8. Maiti B, Li J, de Bruin A, Gordon F, Timmers C, et al. (2005) Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation J Biol Chem. 280: 18211-18220.
9. Pandit SK, Westendorp B, Nantasanti S, van Liere E, Tooten PCJ, et al. (2012) E2F8 is essential for polyploidization in mammalian cells Nat Cell Biol. 14: 1181-1191.
10. Westendorp B, Mokry M, Groot Koerkamp MJ, Holstege FC, Cuppen E, et al. (2012) E2F7 represses a network of oscillating cell cycle genes to control S-phase progression Nucleic Acids Res. 40(8): 3511-23.
11. Weijts BGMW, Bakker WJ, Cornelissen PWA, Liang K, Schaftenaar FH, et al. (2012) E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1 EMBO J. 31: 3871-3884.
12. Ouseph MM, Li J, Chen HZ, Pecot T, Wenzel P, et al. (2012) Atypical E2F repressors and activators coordinate placental development Dev Cell. 22: 849-862.
13. Hogan BM, Bos FL, Bussmann J, Witte M, Chi NC, et al. (2009) Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting Nat Genet. 41: 396-398.
14. Kazenwadel J, Secker GA, Betterman KL, Harvey NL, (2012) In vitro assays using primary embryonic mouse lymphatic endothelial cells uncover key roles for FGFR1 signalling in lymphangiogenesis PLoS One. 7: e40497.
15. Ruthenburg AJ, Li H, Patel DJ, David Allis C, (2007) Multivalent engagement of chromatin modifications by linked binding modules Nature Reviews Molecular Cell Biology. 8: 983-994.
16. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, et al. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
17. Bussmann J, Bos FL, Urasaki A, Kawakami K, Duckers HJ, et al. (2010) Arteries provide essential guidance cues for lymphatic endothelial cells in the zebrafish trunk Development. 137: 2653-2657.
18. Takahashi T, Yamaguchi S, Chida K, Shibuya M, (2001) A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells EMBO J. 20: 2768-2778.
19. Takahashi T, Shibuya M, (1997) The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts Oncogene. 14: 2079-2089.
20. Lawson ND, Mugford JW, Diamond BA, Weinstein BM, (2003) Phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development Genes Dev. 17: 1346-1351.
21. Hagerling R, Pollmann C, Andreas M, Schmidt C, Nurmi H, et al. (2013) A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy EMBO J. 32: 629-644.
22. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y, (2002) A complex with chromatin modifiers that occupies E2F- and myc-responsive genes in G0 cells Science. 296: 1132-1136.
23. Korenjak M, Anderssen E, Ramaswamy S, Whetstine JR, Dyson NJ, (2012) RBF binding to both canonical E2F targets and noncanonical targets depends on functional dE2F/dDP complexes Mol Cell Biol. 32: 4375-4387.
24. Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, et al. (2006) E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer Oncogene. 25: 230-239.
25. Rojas DA, Perez-Munizaga DA, Centanin L, Antonelli M, Wappner P, et al. (2007) Cloning of hif-1alpha and hif-2alpha and mRNA expression pattern during development in zebrafish Gene Expr Patterns. 7: 339-345.
26. Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, et al. (2006) Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2 Cancer Res. 66: 2650-2657.
27. Laakkonen P, Waltari M, Holopainen T, Takahashi T, Pytowski B, et al. (2007) Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth Cancer Res. 67: 593-599.
28. Lawson ND, Weinstein BM, (2002) In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 248: 307-318.
29. Blazejczyk M, Miron M, Nadon R (2007) FlexArray: A statistical data analysis software for gene expression microarrays.
30. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat Protoc. 4: 44-57.
31. Huang da W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists Nucleic Acids Res. 37: 1-13.
32. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: Tool for the unification of biology. the gene ontology consortium Nat Genet 25: 25-29.
33. Bussmann J, Bakkers J, Schulte-Merker S, (2007) Early endocardial morphogenesis requires Scl/Tal1 PLoS Genet. 3: e140.
34. Thompson MA, Ransom DG, Pratt SJ, MacLennan H, Kieran MW, et al. (1998) The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesis Dev Biol. 197: 248-269.
35. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments Clin Chem. 55: 611-622.